/Investor DB

MERGING TRAFFIC — Full Portfolio

3 tracked investments · listed companies and verified rows first

Continuity Biosciencescontinuitybiosciences.comAug 2025SEC filingmedium confidence

Continuity Biosciences develops adaptive precision drug-delivery platforms that combine engineering and biology to help therapies reach their intended targets more effectively.

BiotechDeep TechMedical DevicesBradenton, US

Ramakrishna Venugopalan(Co-Founder & Chief Executive Officer)Robert Whitehead(Co-Founder & Executive Chair)

BoardAlessandro Grattoni(Chief Scientific Advisor)

Board seatAllen R. Weiss· per SEC Form D · $12M raise · filed Aug 2025

Intecrowdintecrowd.cominFeb 2017SEC filingmedium confidence

Intecrowd is a boutique Workday services partner offering deployment, integration, application management, and reporting/analytics support across HR and finance systems.

Enterprise SoftwareHR TechSaaSOrlando, US

DONALD D MCDOUGAL(Manager and Chief Executive Officer)JOSEPH G WALKER(Chief Operating Officer)

BoardDAVID METCALF(Chairman)

Board seatDavid S Metcalf· per SEC Form D · $1.9M raise · filed Feb 2017

Co-investorsFlorida FundersFlorida Technology Seed Capital Fund

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

MERGING TRAFFIC, INC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.